Cannabix Technologies Inc.
Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Cannabix Technologies Inc. develops marijuana and alcohol breathalyzer technologies for law enforcement, workplaces, and laboratories. Its core products include the BreathLogix autonomous alcohol screening device, which provides contactless, unmanned alcohol breath testing designed for safety-critical industries such as oil and gas, transportation, and maritime. The company also develops marijuana breath testing technology focused on detecting delta-9 THC, the psychoactive component of cannabis, enabling identification of recent marijuana use to support employer and law enforcement impairment assessments. Cannabix operates primarily in North America, Europe, and Australia, with manufacturing and research collaborations including a strategic partnership with Omega Laboratories Inc., an Ohio-based forensic drug testing leader that exclusively processes Cannabix’s delta-9 THC breath sample cartridges in North America. Recent major developments include the granting of a U.S. patent for contactless breath analysis technology in 2025, expanded maritime market penetration with multiple orders for its BreathLogix alcohol screening devices in Europe, and shipment of devices to oilfield transportation companies in Canada. The company also launched a new compact BreathLogix Workplace Series tailored for workplace safety applications and continues progress toward commercialization of marijuana breathalyzer products through R&D and validation partnerships. Cannabix strengthens its business by securing non-brokered private placements, entering distribution and sales agreements, and receiving approval from regulatory bodies such as the Highway Traffic Safety Administration for inclusion of its alcohol screening device in federal listings. Founded in 2010 and headquartered in Vancouver, British Columbia, Cannabix Technologies leverages patented sensor cartridge technology, automated testing platforms, and cloud-based reporting through its BreathLogix Connect portal for real-time data management and identity verification. Its products address safety and compliance needs across diverse sectors including transportation, workplace monitoring, law enforcement, and maritime. Key recent strategic moves include the five-year exclusive commercial partnership with Omega Laboratories for delta-9 THC breathalyzer validation and testing, reinforcing Cannabix’s position in the drug and alcohol testing technology market.
Company News
Cannabix Technologies Delivers First Breath-Based DOT-Like Multi-Drug Testing Panel for Recent-Use Detection
Cannabix Technologies Files Provisional Patent Application for BCU-Enabled Point-of-Care Marijuana Breath Testing
Cannabix's BreathLogix Alcohol Screening Solution Enters U.S. Manufacturing Workplace Market with Deployment at Alabama Facility
Cannabix Technologies Deploys BreathLogix Alcohol Monitoring System with Lake County Community Corrections in Indiana's Second-Most Populous County
Cannabix Technologies Deploys BreathLogix Alcohol System at Montana's Big Horn County Probation and Pre-Trial Services Department Under State's 24/7 Sobriety Program
Cannabix Targets Combat Sports Market for Commercial Rollout of Marijuana Breath Test at ABC Boxing & MMA Conference
Cannabix Technologies Annual General Meeting Results
Cannabix Technologies and Omega Laboratories Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection
Omega Laboratories and Cannabix Technologies Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection
Cannabix Technologies Announces Detection of Methamphetamine and Amphetamine in Human Breath
Cannabix Technologies Announces First BreathLogix Alcohol Device Deployment to West Africa for Mining Sector
Cannabix Technologies Announces Deployment of Marijuana Breath Test (MBT) with Major Industrial Operator in Quebec
Cannabix Expands BreathLogix Alcohol Screening Technology into Mining, Municipal and Aviation Sectors in Australia
Cannabix Marijuana Breath Test Achieves Major Milestone: Breath Collection Unit Secures UL and CSA Certifications
Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Workplace Drug and Alcohol Testing Clinic
Omega Laboratories to Host Educational Panels and Present Cannabix Marijuana Breath Test Solution at the 2026 NDASA Conference in California
Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Virginia based Industrial Manufacturing Client
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT)
Journal of Analytical Toxicology Publishes Peer‑Reviewed Validation Study Demonstrating Accuracy of Omega Laboratories' Test Method for Detecting Marijuana in Breath Samples Using Cannabix Technologies' Breath Collection Unit